NBTX Nanobiotix S.A.
$34.53▲ +9.51%
Healthcare
Other
After hours
$34.53▲ +0.00%
Oct 27, 4:00 PM ET
Volume 130.0K
Avg Volume (10D) 127.0K
Key Metrics & Fundamentals
Market Cap
$1.76B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.37 - 57.14
% vs 50 MA
4.17%
% vs 200 MA
2.57%
RSI-14
65.8
MACD Histogram
+1.7000
Beta (1Y vs SPY)
1.88
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Nanobiotix (ENXTPA:NANO) Could Be 46% Undervalued As Melanoma Trial Results Land
Simply Wall St. · Oct 26, 2026 7:31 PM ET
Nanobiotix stock gains on positive melanoma trial data
Investing.com · Oct 26, 2026 11:35 AM ET
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
GlobeNewswire · Oct 24, 2026 7:00 AM ET
Voting Rights and Shares Capital of the Company
GlobeNewswire · Oct 20, 2026 4:15 PM ET
Nanobiotix (ENXTPA:NANO) Could Be 59% Undervalued After Its CFO Change
Simply Wall St. · Oct 10, 2026 1:11 PM ET
Nanobiotix Appoints Arnd Christ as CFO
MT Newswires · Oct 1, 2026 4:46 PM ET
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
GlobeNewswire · Oct 1, 2026 4:15 PM ET
Can J&J’s Partnership Drive More Upside for Nanobiotix?
Insider Monkey · Sep 28, 2026 3:31 PM ET
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
GlobeNewswire · Sep 24, 2026 4:15 PM ET
Voting Rights and Shares Capital of the Company
GlobeNewswire · Sep 22, 2026 4:15 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.